Hospital
Sparrow Eaton Hospital
Sparrow Eaton Hospital was paid $13.22M by Medicaid between Jan 2018 and Dec 2024, across 169 billing codes. Its largest line is 99285, emergency room visit (most serious) — 24% of everything it billed.
33Billing provider infoSPARROW EATON HOSPITAL
CHARLOTTE, MI 48813
CHARLOTTE, MI 48813
33aNPI1942254529assigned 05/19/2006
33bProvider typeCritical Access Hospital
28Total paid$13.22M
24GClaims288,027
24DCodes billed169
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#5 of 31
Median peer was paid$6.03M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RUSSIAN, MISTY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,632 | $1.12M | |
| 2019 | 33,574 | $1.13M | |
| 2020 | 29,635 | $1.32M | |
| 2021 | 46,464 | $2.20M | |
| 2022 | 51,169 | $2.69M | |
| 2023 | 52,861 | $2.71M | |
| 2024incomplete | 39,692 | $2.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 24% | 8,342 | 7,698 | $3.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 8,932 | 8,416 | $2.14M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 10,911 | 10,382 | $1.71M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.0% | 6,624 | 6,012 | $798K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.2% | 17,829 | 4,835 | $561K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.4% | 10,450 | 8,905 | $448K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 2,076 | 2,000 | $381K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.7% | 3,128 | 2,621 | $362K |
| A0425 | Ground mileage, per statute mile | 2.6% | 4,343 | 3,764 | $350K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 2.6% | 1,544 | 1,430 | $341K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.8% | 5,873 | 5,021 | $242K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 4,695 | 4,499 | $214K |
157 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 2,264 | $207K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 4,535 | $200K |
| A0429 | Emergency ambulance ride, basic life support | 1.3% | 1,082 | $172K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 4,145 | $152K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 1,255 | $151K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.0% | 8,049 | $132K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 723 | $108K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,046 | $100K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,873 | $99K |
| 97161 | <1% | 1,648 | $96K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 661 | $94K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 661 | $90K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,084 | $66K |
| 80061 | Lipid panel | <1% | 5,751 | $59K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,942 | $43K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 132 | $39K |
| 73564 | <1% | 968 | $38K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 301 | $33K |
| 80053 | Comprehensive metabolic panel | <1% | 20,895 | $33K |
| 73630 | <1% | 1,455 | $31K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 140 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,433 | $28K |
| 73130 | <1% | 1,148 | $28K | |
| 73030 | <1% | 947 | $27K | |
| 73610 | <1% | 989 | $25K | |
| 94060 | <1% | 126 | $24K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 317 | $23K |
| 76830 | Ultrasound, transvaginal | <1% | 277 | $22K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 700 | $21K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,282 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,504 | $20K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 135 | $18K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 249 | $16K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 494 | $16K |
| 73110 | <1% | 597 | $15K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 847 | $14K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 80 | $14K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,403 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,856 | $11K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 315 | $10K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,147 | $9K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 13 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 721 | $8K |
| 82607 | <1% | 1,809 | $8K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 588 | $7K |
| 73502 | <1% | 226 | $7K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 108 | $6K |
| 72110 | <1% | 144 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,220 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 69 | $5K |
| 86803 | <1% | 1,039 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 624 | $5K |
| 82728 | <1% | 1,016 | $5K | |
| 84439 | <1% | 1,918 | $5K | |
| 83880 | <1% | 1,648 | $5K | |
| 85027 | <1% | 3,011 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,590 | $4K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 37 | $4K |
| 93976 | <1% | 43 | $3K | |
| 73562 | <1% | 115 | $3K | |
| 86900 | <1% | 422 | $3K | |
| 93971 | <1% | 42 | $3K | |
| 83550 | <1% | 1,000 | $3K | |
| 87631 | <1% | 63 | $3K | |
| 82652 | <1% | 279 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,281 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,140 | $3K |
| 85610 | <1% | 4,271 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,470 | $2K |
| 83540 | <1% | 1,068 | $2K | |
| 74018 | <1% | 136 | $2K | |
| 84702 | <1% | 600 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 390 | $2K |
| 83735 | <1% | 5,175 | $2K | |
| 82043 | <1% | 1,223 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,886 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 168 | $2K |
| 76536 | <1% | 24 | $2K | |
| 96367 | <1% | 41 | $2K | |
| 97162 | <1% | 25 | $1K | |
| 86140 | <1% | 3,731 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 89 | $1K |
| 73140 | <1% | 39 | $1K | |
| 93017 | <1% | 12 | $1K | |
| 87506 | <1% | 12 | $975.84 | |
| 81001 | <1% | 6,156 | $972.24 | |
| 73100 | <1% | 16 | $904.32 | |
| 82570 | <1% | 592 | $895.83 | |
| 76642 | <1% | 14 | $880.49 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,435 | $785.13 |
| 86780 | <1% | 119 | $767.83 | |
| 86850 | <1% | 313 | $764.84 | |
| 83690 | <1% | 3,926 | $605.45 | |
| 85652 | <1% | 1,017 | $561.15 | |
| 74022 | <1% | 68 | $560.49 | |
| 85730 | <1% | 1,599 | $556.87 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 214 | $537.75 |
| 87077 | <1% | 687 | $516.46 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,582 | $457.92 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 34 | $454.82 |
| 84703 | <1% | 2,414 | $444.02 | |
| 73590 | <1% | 26 | $434.39 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $355.45 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28 | $288.17 |
| 80076 | <1% | 282 | $280.76 | |
| 86038 | <1% | 76 | $260.67 | |
| 86901 | <1% | 425 | $242.29 | |
| 81003 | <1% | 2,754 | $228.37 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,518 | $224.53 |
| 94726 | <1% | 112 | $211.17 | |
| 84484 | <1% | 3,952 | $202.08 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 38 | $196.68 |
| 87186 | <1% | 420 | $194.71 | |
| 85007 | <1% | 316 | $166.61 | |
| 87340 | <1% | 39 | $161.52 | |
| 85379 | <1% | 1,213 | $150.20 | |
| 87420 | <1% | 362 | $148.88 | |
| 82746 | <1% | 25 | $140.33 | |
| 83516 | <1% | 13 | $136.27 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 77 | $135.28 |
| 83605 | <1% | 3,795 | $134.07 | |
| 82784 | <1% | 25 | $129.00 | |
| 83970 | <1% | 13 | $123.47 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $51.36 |
| 85660 | <1% | 12 | $48.21 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 12 | $38.78 |
| 82948 | <1% | 212 | $29.89 | |
| 85651 | <1% | 14 | $19.00 | |
| 87070 | <1% | 15 | $16.26 | |
| 82962 | <1% | 1,038 | $9.21 | |
| 81002 | <1% | 330 | $3.97 | |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $1.42 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,872 | $0.22 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 426 | $0.13 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 682 | $0.00 |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | 0% | 59 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 426 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 235 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 118 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 111 | $0.00 |
| 94729 | 0% | 30 | $0.00 | |
| 81025 | 0% | 350 | $0.00 | |
| 87210 | 0% | 17 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 85 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,894 | $0.00 |
| 96376 | 0% | 957 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 284 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 113 | $0.00 |
| 87040 | 0% | 138 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 147 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 477 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 204 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 254 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 14 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 14 | $0.00 |
| 82550 | 0% | 13 | $0.00 | |
| 95886 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUSSIAN, MISTY (SUPERVISOR, PROVIDER ENROLLMENT)
Parent organizationSPARROW HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Edward W Sparrow Hospital Association | Lansing, MI | $125.88M |
| Metropolitan Hospital | Wyoming, MI | $100.96M |
| Sparrow Ionia Hospital | Ionia, MI | $13.76M |
| Sparrow Clinton Hospital | Saint Johns, MI | $8.68M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $5.81M |
| Sparrow Carson Hospital | Carson City, MI | $5.48M |
| Edward W. Sparrow Hospital Association | East Lansing, MI | $5.43M |
| Sparrow Ionia Hospital | Ionia, MI | $3.49M |
| Sparrow Eaton Hospital | Charlotte, MI | $3.12M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.77M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.61M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.48M |
| Edward W. Sparrow Hospital Association | Mason, MI | $2.44M |
| Sparrow Community Care | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $1.85M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.83M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.65M |
| Sparrow Ionia Hospital | Portland, MI | $1.61M |
| Sparrow Carson Hospital | Ithaca, MI | $1.54M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.